Clinical Trial Update: Decrease in Circulating Tumour Cell Count Reflects the Effectiveness of Postoperative Adjuvant Transarterial Chemoembolization (TACE) in Preventing Hepatocellular Carcinoma Recurrence [NA]

View source ↗

Summary

A completed clinical trial from Guangdong Provincial People's Hospital found that decreases in circulating tumor cell count were associated with the effectivene…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Guangdong Provincial People's Hospital | Conditions: Circulating Tumor Cell;, Hepatocellular Carcinoma | NA | Status: COMPLETED